InCarda Therapeutics Investors

17 investors on Angel Roster list InCarda Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Sweden and China.

Investors are matched on the company name in their portfolio, so companies that share the name InCarda Therapeutics can appear together.

Investors listed
17
With verified email
41%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 17 InCarda Therapeutics investors

The most complete profiles first. Showing 17 of 17.

  • Chris JacksonVerified

    Venture Capital, Investor · United States

    SeedHealth CareE-commerceWomen FoundedLife Science

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Jason DoddVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Keith UnderwoodVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Per Samuelsson

    Venture Capital, Private Equity Firm, Investor · Sweden

    SeedHealth CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Staffan Lindstrand

    Venture Capital, Private Equity Firm, Investor · Sweden

    SeedHealth CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Lisa Shi

    Venture Capital, Private Equity Firm, Micro VC · China

    Health CareHospitalsCybersecurityWellness

    Portfolio: Indi Molecular, ICON Aircraft, CardioGen Sciences, Chimerix and 50 more

    Contact details available

  • Melina Mathur

    Venture Capital, Micro VC · United States

    Health CareHospitalsCybersecurityWellness

    Portfolio: Indi Molecular, ICON Aircraft, CardioGen Sciences, Chimerix and 50 more

    Contact details available

  • Nikki Matthews

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many InCarda Therapeutics investors are on Angel Roster?

Angel Roster lists 17 InCarda Therapeutics investors. 7 of them (41%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (17), Private Equity Firms (3) and Micro VC Firms (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do InCarda Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (7) and Series B (1).

Where are InCarda Therapeutics investors based?

Most are based in the United States (13), Sweden (2) and China (1).

Which companies have InCarda Therapeutics investors backed?

The most-backed portfolio companies among them are Rainier Therapeutics (15), Audentes Therapeutics (11), Aeovian Pharmaceuticals (9), XyloCor Therapeutics (9) and Checkmate Pharmaceuticals (9).

How do I contact InCarda Therapeutics investors?

Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.